Strata Critical Medical (SRTA) Other Operating Expenses (2019 - 2026)

Strata Critical Medical (SRTA) has reported Other Operating Expenses for 8 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses rose 244.69% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at -$7.1 million (up 45.56% YoY), while the FY2025 annual figure was $2.6 million, up 138.91% from the prior year.
• Other Operating Expenses improved to $1.5 million in Q1 2026 per SRTA's latest filing, from -$100.7 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $56.9 million in Q3 2023 and bottomed at -$100.7 million in Q4 2025.
• Historically, Other Operating Expenses has averaged $14.2 million across 5 years, with a median of $38.2 million in 2025.
• Annual changes were most pronounced in 2022 — Other Operating Expenses sank 402.67% — and 2023, when it surged 266.37%.
• Strata Critical Medical's Other Operating Expenses stood at $17.3 million in 2022, then jumped by 160.95% to $45.3 million in 2023, then tumbled by 306.71% to -$93.6 million in 2024, then dropped by 7.67% to -$100.7 million in 2025, then jumped by 101.48% to $1.5 million in 2026.
• Business Quant data shows SRTA's Other Operating Expenses at $1.5 million in Q1 2026, -$100.7 million in Q4 2025, and $38.2 million in Q3 2025.